EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center

Arun Bahadur Chand iD, Ajaya Basnet, Bhagwan Maharjan, Ganesh Rai, Yadav Prasad Joshi, Lok Raj Bhatt, Bindu Sen, Shiba Kumar Rai

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0301210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Arun Bahadur Chand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, KIST Medical College and Teaching Hospital, Lalitpur, Nepal. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multidrug-resistant tuberculosis (MDR-TB), characterized by isoniazid and rifampicin resistance, is caused by chromosomal mutations that restrict treatment options and complicate tuberculosis management. This study sought to investigate the prevalence of pre-extensively drug-resistant (pre-XDR) and extensively drug-resistant (XDR) tuberculosis, as well as mutation pattern, in Nepalese patients with MDR/rifampicin-resistant (RR)-TB strains.

Methods

A cross-sectional study was conducted on MDR/RR-TB patients at the German Nepal Tuberculosis Project from June 2017 to June 2018. The MTBDRsl line probe assay identified pre-XDR-TB and XDR-TB. Pre-XDR-TB included MDR/RR-TB with resistance to any fluoroquinolone (FLQ), while XDR-TB included MDR/RR-TB with resistance to any FLQ and at least one additional group A drug. Mutation status was determined by comparing bands on reaction zones [ gyrA and gyrB for FLQ resistance, rrs for SILD resistance, and eis for low-level kanamycin resistance, according to the GenoType MTBDRsl VER 2.0, Hain Lifescience GmbH, Nehren, Germany definition of pre-XDR and XDR] to the evaluation sheet. SPSS version 17.0 was used for data analysis.

Results

Out of a total of 171 patients with MDR/RR-TB, 160 had (93.57%) had MTBC, of whom 57 (35.63%) had pre-XDR-TB and 10 (6.25%) had XDR-TB. Among the pre-XDR-TB strains, 56 (98.25%) were FLQ resistant, while 1 (1.75%) was SLID resistant. The most frequent mutations were found at codons MUT3C (57.14%, 32/56) and MUT1 (23.21%, 13/56) of the gyrA gene. One patient had SLID resistant genotype at the MUT1 codon of the rrs gene (100%, 1/1). XDR-TB mutation bands were mostly detected on MUT1 (30%, 3/10) of the gyrA and rrs , MUT3C (30%, 3/10) of the gyrA , and MUT1 (30%, 3/10) of the rrs .

Conclusions

Pre-XDR-TB had a significantly higher likelihood than XDR-TB, with different specific mutation bands present in gyrA and rrs genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisExtensively Drug-Resistant TuberculosisAntitubercular AgentsTuberculosis, Multidrug-ResistantMutationHumansNepalMaleFemaleAdultCross-Sectional StudiesMiddle AgedMicrobial Sensitivity TestsRifampinIsoniazidDrug Resistance, Multiple, BacterialYoung AdultFluoroquinolonesAdolescentAged

Substanzen

Antitubercular AgentsRifampinIsoniazidFluoroquinolones

Autor:innen und Institutionen

  • Department of Microbiology, KIST Medical College and Teaching Hospital, Lalitpur, Nepal.
  • Department of Medical Microbiology, Shi-Gan International College of Science and Technology, Kathmandu, Nepal.
  • German Nepal Tuberculosis Project, Kathmandu, Nepal.
  • Department of Public Health, Manmohan Memorial Institute of Health Sciences, Kathmandu, Nepal.
  • Department of Dentistry, KIST Medical College and Teaching Hospital, Lalitpur, Nepal.
  • Department of Microbiology, Nepal Medical College Teaching Hospital, Kathmandu, Nepal.

ORCID-Profile: Arun Bahadur Chand

Zitieren

APA

Chand, A. B., Basnet, A., Maharjan, B., Rai, G., Joshi, Y. P., Bhatt, L. R., Sen, B., & Rai, S. K. (2024). Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center. PLOS ONE. https://doi.org/10.1371/journal.pone.0301210

Vancouver

Chand AB, Basnet A, Maharjan B, Rai G, Joshi YP, Bhatt LR, et al. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center. PLOS ONE. 2024. doi:10.1371/journal.pone.0301210

BibTeX
@article{Chand2024,
  author = {Chand, Arun Bahadur and Basnet, Ajaya and Maharjan, Bhagwan and Rai, Ganesh and Joshi, Yadav Prasad and Bhatt, Lok Raj and Sen, Bindu and Rai, Shiba Kumar},
  title = {Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0301210}
}
Kostenlos starten →